SemBioSys granted U.S. patent for antibody production

By Lisa Kerner

Charlotte, N.C., Sept. 7 - SemBioSys Genetics Inc. was granted U.S. Patent No. 7,098,383 for claims directed to the production of antibodies in association with oilbodies.

"We believe our oilbody-oleosin technology is an efficient method for antibody production and recovery with substantial savings in both capital and cost-of-goods," president and chief executive officer Andrew Baum said in a news release.

In August the Calgary, Alta.-based biotechnology company was issued U.S. Patent No. 7,091,401 which covers chimeric nucleic acid sequences and methods of expression of EGF in plants and plant seeds.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.